Laura Novik

5.6k total citations
7 papers, 378 citations indexed

About

Laura Novik is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Laura Novik has authored 7 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Virology and 3 papers in Immunology. Recurrent topics in Laura Novik's work include HIV Research and Treatment (5 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (2 papers). Laura Novik is often cited by papers focused on HIV Research and Treatment (5 papers), Herpesvirus Infections and Treatments (4 papers) and Virus-based gene therapy research (2 papers). Laura Novik collaborates with scholars based in United States, Russia and France. Laura Novik's co-authors include John R. Mascola, Barney S. Graham, Mary E. Enama, Robert T. Bailer, Richard A. Koup, Mario Roederer, Charla Andrews, Julie E. Martin, Bimal K. Chakrabarti and C. Richter King and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Journal of Viral Hepatitis.

In The Last Decade

Laura Novik

7 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Novik United States	6	188	167	136	126	122	7	378
Kurt Bieler Germany	10	323 1.7×	168 1.0×	114 0.8×	128 1.0×	101 0.8×	11	479
Susan Barnett United States	8	214 1.1×	383 2.3×	113 0.8×	88 0.7×	78 0.6×	12	545
Brenda Larkin United States	8	188 1.0×	173 1.0×	199 1.5×	262 2.1×	53 0.4×	9	521
Eva B. Schadeck United States	6	114 0.6×	174 1.0×	122 0.9×	67 0.5×	69 0.6×	6	313
Nina Malkevitch United States	11	379 2.0×	255 1.5×	183 1.3×	80 0.6×	178 1.5×	11	468
Ang Bian United States	7	78 0.4×	182 1.1×	180 1.3×	157 1.2×	251 2.1×	9	492
D. C. Montefiori United States	6	344 1.8×	210 1.3×	153 1.1×	225 1.8×	45 0.4×	14	508
Steve Norley Germany	12	297 1.6×	173 1.0×	174 1.3×	145 1.2×	46 0.4×	18	474
Rosemarie D. Mason United States	13	281 1.5×	258 1.5×	145 1.1×	148 1.2×	49 0.4×	38	484
Mike M. Pütz United Kingdom	10	269 1.4×	184 1.1×	246 1.8×	40 0.3×	88 0.7×	10	454

Countries citing papers authored by Laura Novik

Since Specialization

Citations

This map shows the geographic impact of Laura Novik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Novik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Novik more than expected).

Fields of papers citing papers by Laura Novik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Novik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Novik. The network helps show where Laura Novik may publish in the future.

Co-authorship network of co-authors of Laura Novik

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Novik. A scholar is included among the top collaborators of Laura Novik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Novik. Laura Novik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Crank, Michelle C., Eleanor Wilson, Laura Novik, et al.. (2016). Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012). PLoS ONE. 11(11). e0166393–e0166393. 10 indexed citations

2.

Enama, Mary E., Julie E. Ledgerwood, Laura Novik, et al.. (2014). Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011). PLoS ONE. 9(3). e91366–e91366. 22 indexed citations

3.

Sarwar, Uzma, Laura Novik, Mary E. Enama, et al.. (2014). Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical Trial. PLoS ONE. 9(9). e106240–e106240. 5 indexed citations

4.

Koup, Richard A., Mario Roederer, Laurie Lamoreaux, et al.. (2010). Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses. PLoS ONE. 5(2). e9015–e9015. 102 indexed citations

5.

Novik, Laura, et al.. (2009). P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011). Retrovirology. 6(S3). 1 indexed citations

6.

Novik, Laura, et al.. (2008). Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. Journal of Viral Hepatitis. 15(s2). 43–46. 10 indexed citations

7.

Catanzaro, Andrew, Richard A. Koup, Mario Roederer, et al.. (2006). Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector. The Journal of Infectious Diseases. 194(12). 1638–1649. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact